-
1 Comment
Encompass Health Corporation is currently in a long term uptrend where the price is trading 1.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Encompass Health Corporation's total revenue rose by 2.5% to $1B since the same quarter in the previous year.
Its net income has increased by 27.2% to $86M since the same quarter in the previous year.
Finally, its free cash flow grew by 65.5% to $133M since the same quarter in the previous year.
Based on the above factors, Encompass Health Corporation gets an overall score of 5/5.
Exchange | NYSE |
---|---|
CurrencyCode | USD |
ISIN | US29261A1007 |
Sector | Healthcare |
Industry | Medical Care Facilities |
Beta | 0.76 |
---|---|
Market Cap | 10B |
PE Ratio | 22.59 |
Target Price | 117.1818 |
Dividend Yield | 0.7% |
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EHC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025